ArticleBulletin of the World Health Organization2026
Evaluation of an application for investments in cataract surgery, Ethiopia.
Article in Bulletin of the World Health Organization, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Problem: The World Health Organization recommends a benchmark for uncorrected visual acuity of ≥ 6/12 in 80% of patients at 4 to 6 weeks following cataract surgery. In low-resource countries, reaching this benchmark is challenging and assessing progress is difficult. Approach: This intervention involved modest investments recommended by the Better Operative Outcome Software Tool (BOOST) application (app). The investments targeted specific causes of poor cataract surgery results at hospitals in Ethiopia to improve vision outcomes. Fifteen ophthalmic surgeons from 11 public secondary and tertiary eye care centres in five regional Ethiopian states collected pre-intervention data using the BOOST app. Based on 20 consecutive patients with vision < 6/60, BOOST identified case selection, intraoperative complications or postoperative refractive error as the leading causes of poor outcomes. Each facility then invested 2500 United States dollars (US$) to target its leading cause, recorded outcomes for 60 consecutive cataract patients, and then compared the proportion with uncorrected vision ≥ 6/12 before and after the intervention. Local setting: All 11 centres are Orbis International partners and services provided at the facilities are highly subsidized or free of charge. Relevant changes: After implementing targeted interventions at the facilities to address undetected ocular comorbidity, surgical complications or postoperative refractive errors, 501 (56.0%) of 894 patients had good results (≥ 6/12), compared to 289 (32.2%) of 897 patients before the intervention. Lessons learnt: Using the BOOST app as an approach for quality monitoring and improvement enables benchmarking across contexts and can enhance surgical outcomes when paired with recommended targeted investments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.